Table 5.
Details regarding disease severity indicators in relation to different antibody titers in the CSF and serum.
| CSF | Serum | |||||||
|---|---|---|---|---|---|---|---|---|
| Negative | Weakly positive | Positive | Strongly positive | Negative | Weakly positive | Positive | Strongly positive | |
| ICU (no.) | 4 | 5 | 29 | 19 | 21 | 16 | 19 | 5 |
| Ventilator use (no.) | 0 | 1 | 7 | 9 | 6 | 2 | 6 | 2 |
| Tumor (no.) | 0 | 0 | 5 | 5 | 3 | 0 | 6 | 1 |
| Surgery (no.) | 0 | 0 | 1 | 2 | 1 | 0 | 1 | 1 |
| Median hospitalization days | 14 | 19.5 | 22 | 30 | 21 | 20 | 23 | 24.5 |
| Median hospitalization costs (USD) | 2439.89 | 5041.56 | 4676.74 | 6391.01 | 4802.69 | 4919.42 | 4700.65 | 4535.96 |
| Prognosis | ||||||||
| GOS ≥4 | 13 | 9 | 107 | 24 | 28 | 22 | 95 | 8 |
| 2–3 | 2 | 1 | 14 | 6 | 5 | 2 | 15 | 1 |
| 1 | 0 | 0 | 3 | 2 | 2 | 1 | 3 | 1 |